Decreased plasma miR-335 expression in patients with acute ischemic stroke and its association with calmodulin expression

Journal of International Medical Research

Volumn 44, Issue 6, 2016, Pages 1331-1338

  Zhao, Bin ^a   Zhu, Zilong ^b   Hao, Junwei ^a   Wan, Zongming ^c   Guo, Xiaoqin ^c  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b TIANJIN HUANHU HOSPITAL   (China)

^c Logistics College of Chinese Armed Police Forces   (China)

Author keywords

acute ischemic stroke; calmodulin; diagnosis; MicroRNA 335

Indexed keywords

CALMODULIN; MICRORNA; MICRORNA 335; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MIRN335 MICRORNA, HUMAN;

AGED; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PREDICTOR VARIABLE; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SCORING SYSTEM; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; BINDING SITE; BLOOD; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; SIGNAL TRANSDUCTION; STROKE;

AGED; BASE SEQUENCE; BINDING SITES; BIOMARKERS; BRAIN ISCHEMIA; CALMODULIN; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MICRORNAS; MIDDLE AGED; SIGNAL TRANSDUCTION; STROKE;

EID: 85006489138     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060516665707     Document Type: Article

References (31)

1. Alonso de Leciñana M, Gutiérrez-Fernández M, Romano M. Strategies to improve recovery in acute ischemic stroke patients: Iberoamerican stroke group consensus. Int J Stroke 2014; 9: 503–513.
2. Baldwin KA, McCoy SL. Making a case for acute ischemic stroke. J Pharm Pract 2010; 23: 387–397.
3. Adams HP, Jr. del Zoppo G, Alberts MJ. Guidelines for the early management of adults with ischemic stroke: a guideline from the American heart association/American stroke association stroke council, clinical cardiology council, cardiovascular radiology and intervention council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups: the American academy of neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 2007; 115: e478–e534.
4. Wang DZ, Rose JA, Honings DS. Treating acute stroke patients with intravenous tPA. The OSF stroke network experience. Stroke 2000; 31: 77–81.
5. Katzan IL, Hammer MD, Hixson ED. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol 2004; 61: 346–350.
6. Barber PA, Zhang J, Demchuk AM. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 2001; 56: 1015–1020.
7. Jia L, Hao F, Wang W. Circulating miR-145 is associated with plasma high-sensitivity C-reactive protein in acute ischemic stroke patients. Cell Biochem Funct 2015; 33: 314–319.
8. Sørensen SS, Nygaard AB, Nielsen MY. miRNA expression profiles in cerebrospinal fluid and blood of patients with acute ischemic stroke. Transl Stroke Res 2014; 5: 711–718.
9. Osman A. MicroRNAs in health and disease–basic science and clinical applications. Clin Lab 2012; 58: 393–402.
10. Mendell JT, Olson EN. MicroRNAs in stress signaling and human disease. Cell 2012; 148: 1172–1187.
11. Rink C, Khanna S. MicroRNA in ischemic stroke etiology and pathology. Physiol Genomics 2011; 43: 521–528.
12. Tan JR, Koo YX, Kaur P. microRNAs in stroke pathogenesis. Curr Mol Med 2011; 11: 76–92.
13. Zeng Y, Liu JX, Yan ZP. Potential microRNA biomarkers for acute ischemic stroke. Int J Mol Med 2015; 36: 1639–1647.
14. Liu Y, Zhang J, Han R. Downregulation of serum brain specific microRNA is associated with inflammation and infarct volume in acute ischemic stroke. J Clin Neurosci 2015; 22: 291–295.
15. Chen X, Ba Y, Ma L. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18: 997–1006.
16. Yuan M, Tang Y, Zhou C. Elevated plasma CaM expression in patients with acute cerebral infarction predicts poor outcomes and is inversely associated with miR-26b expression. Int J Neurosci 2016; 126: 408–414.
17. Bao MH, Xiao Y, Zhang QS. Meta-Analysis of miR-146a Polymorphisms association with coronary artery diseases and ischemic stroke. Int J Mol Sci 2015; 16: 14305–14317.
18. Samaraweera L, Grandinetti KB, Huang R. MicroRNAs define distinct human neuroblastoma cell phenotypes and regulate their differentiation and tumorigenicity. BMC Cancer 2014; 14: 309–309.
19. Dharap A, Bowen K, Place R. Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. J Cereb Blood Flow Metab 2009; 29: 675–687.
20. Mitchell PS, Parkin RK, Kroh EM. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008; 105: 10513–10518.
21. Li Y, Kowdley KV. Method for microRNA isolation from clinical serum samples. Anal Biochem 2012; 431: 69–75.
22. Weng H, Shen C, Hirokawa G. Plasma miR-124 as a biomarker for cerebral infarction. Biomed Res 2011; 32: 135–141.
23. Zeng L, Liu J, Wang Y. MicroRNA-210 as a novel blood biomarker in acute cerebral ischemia. Front Biosci (Elite Ed) 2011; 3: 1265–1272.
24. Sathyan P, Golden HB, Miranda RC. Competing interactions between micro-RNAs determine neural progenitor survival and proliferation after ethanol exposure: evidence from an ex vivo model of the fetal cerebral cortical neuroepithelium. J Neurosci 2007; 27: 8546–8557.
25. Yuan M, Tang Y, Yuan H. Negative Regulation of Calmodulin by miR-335 in Acute Ischemic Stroke. Medical Science Journal of Central South China 2015; 43: 276–280.
26. Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010; 79: 351–379.
27. Moha Ou Maati H, Widmann C, Sedjelmaci D. Mapacalcine protects mouse neurons against hypoxia by blocking cell calcium overload. PLoS One 2013; 8: e66194–e66194.
28. Tang LH, Xia ZY, Zhao B. Phosphocreatine preconditioning attenuates apoptosis in ischemia-reperfusion injury of rat brain. J Biomed Biotechnol 2011; 2011: 107091–107091.
29. Brennecke J, Stark A, Russell RB. Principles of microRNA-target recognition. PLoS Biol 2005; 3: e85–e85.
30. Krek A, Grün D, Poy MN. Combinatorial microRNA target predictions. Nat Genet 2005; 37: 495–500.
31. Mayr M, Zampetaki A, Kiechl S. MicroRNA biomarkers for failing hearts? Eur Heart J 2013; 34: 2782–2783.